TSO3 announces financial results for Q3 2009 and updates on negotiations with 3M

 Stock symbol: TSX: TOS Outstanding shares: 47,863,402 Highlights of Q3 2009 and recent weeks: - Progressed in due diligence and negotiations with 3M toward signing a channel partner agreement within the agreed upon 90 day period; - Completed new cycle development and initiated data collection to support filings with regulatory agencies in Canada, United States and Europe; - Filed patent applications to extend protection for new cycles; - John H. Stroger Hospital of Cook County announced in press release adoption of STERIZONE(R) technology. Benefits cited include cost- effective and eco-friendliness; - Continued interaction with US regulatory agency supporting request for expanded claims of sterile efficacy for multi-channel flexible endoscopes. 

 SUMMARY OF OPERATING RESULTS Periods ended September 30, 2009 (Unaudited) ------------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------- THIRD QUARTER NINE MONTHS ------------- ----------- ------------------------------------------------------------------------- 2009 2008 2009 2008 ------------------------------------------------------------------------- SALES $ 126,162 $ 725,257 $1,170,276 $1,853,584 ------------------------------------------------------------------------- EXPENSES ------------------------------------------------------------------------- Operating 359,275 704,574 1,530,267 1,864,636 ------------------------------------------------------------------------- Sales & Marketing 524,748 724,311 1,780,369 2,919,073 ------------------------------------------------------------------------- Research & Development 876,118 634,390 2,390,273 1,870,407 ------------------------------------------------------------------------- Administrative 718,322 708,284 2,240,998 2,626,534 ------------------------------------------------------------------------- Financial 6,488 6,092 16,387 18,309 ------------------------------------------------------------------------- 2,484,951 2,777,651 7,958,294 9,298,959 ------------------------------------------------------------------------- ------------------------------------------------------------------------- OPERATING LOSS 2,358,789 2,052,394 6,788,018 7,445,375 ------------------------------------------------------------------------- Other Revenues 71,078 203,535 249,500 708,952 ------------------------------------------------------------------------- NET LOSS AND COMPREHENSIVE LOSS $2,287,711 $1,848,859 $6,538,518 $6,736,423 ------------------------------------------------------------------------- BASIC AND DILUTED NET LOSS PER SHARE $ 0.05 $ 0.04 $ 0.14 $ 0.14 ------------------------------------------------------------------------- WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING 47,863,402 47,863,402 47,863,402 47,863,402 ------------------------------------------------------------------------- ------------------------------------------------------------------------- OPERATING RESULTS ANALYSIS ------------------------------------------------------------------------- ------------------------------------------------------------------------- 

 The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.